KALA BIO logo

KALA BIO

KALA | NASDAQ
Chart Builder DCF Calculator
$0.43
-$0.07 (-14.56%)
At close: Sep 30, 2026, 4:00 PM ET
Split Notice: KALA BIO underwent a 1-for-30 split on Nov 16, 2026. Please be aware that not all data may be fully adjusted for the split yet.
-14.56%

Rating

Updated: Aug 24, 2026
28.5
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $8.3M
1D Range
0.41 0.54
52W Range
0.40 95.50

Valuation (TTM)

PE -0.01
PB 0.92
EV/EBITDA -0.12

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $18.25
Loading financial charts...

Profile

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanopart...

Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date Jul 20, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Hold
Price Target
$18.25
Upside
+4144.19%
Buy (0)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.